Dendritic cell biology and preparation for clinical applications (Review and preliminary results);Biologie dendritickych buněk a jejich příprava pro klinické užití (Přehled a předběžné vysledky)

Klinicka Onkologie

Volumn 14, Issue 3, 2001, Pages 79-84

  Hajek R ^a   Krivanova A ^a   Bourkova L ^a   Doubek, M ^a   Fiserova A ^a   Kovarova L ^a   Musilova R ^a   Buchler T ^a   Penka, M ^a   Vorlicek J ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

Dendritic Cells; Immunotherapy; Vaccination

Indexed keywords

CD34 ANTIGEN; CD40 ANTIGEN; FLT3 LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTING CELL; BONE MARROW; CELL MATURATION; CELLULAR IMMUNITY; CRYOPRESERVATION; CYTOLOGY; DENDRITIC CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOTHERAPY; PHENOTYPE; REVIEW; UMBILICAL CORD BLOOD; VACCINATION;

EID: 0034942312     PISSN: 0862495X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Generation of T cell clones binding F(ab)2 fragments of the idiotypic immunoglobulin in patients with monoclonal gammopathy
2. Dendritic cells and immune-based therapies
3. Improved met hods for the generation of dendritic cells from nonproliferating progenitors in human blood
4. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability
5. Dramatic increase in the numbers of dendritic cells in the peripheral blood of healthy volunteers treated with Flt3L
6. Reciprocal control of T helper cell and dendritic cell differentiation
7. Identification of a novel cell type in peripheral lymphoid organs of mice
8. Localization of HLA-ABC and DR antigens in human kidney
9. Hematopoietic progenitor cells of lymphocytes and dendritic cells
10. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis
11. Dendritic cells: Unique leukocyte populations which control the primary immune response
12. Isolation and function of human dendritic cells
13. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products
14. Lineage-negative human leukocyte antigen-DR+ cells with the phenotype of undifferentiated dendritic cells in patients with carcinoma of the abdomen and pelvis
15. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature
16. Migration patterns of dendritic leukocytes. Implications for transplantation
17. Dendritic cells and the control of immunity
18. In vivo migration of dendritic cells differentiated in vitro: A chimpanzee model
19. Lymph-borne dendritic leucocytes do not recirculate, but enter the lymph node paracortex to become interdigitating cells
20. Migration patterns of dendritic cells in the mouse. Traffic from the blood, and T cell-dependent and -independent entry to lymphoid tissues
21. Generation of dendritic cells from bone marrow progenitors using GM-CSF, TNF-alpha, and additional cytokines: Antagonistic effects of IL-4 and IFN-gamma and selective involvement of TNF-alpha receptor-1
22. Stem cell factor and the regulation of dendritic cell production from CD34+ progenitors in bone marrow and cord blood
23. Expansion of immunostimulatory dendritic cells among the myeloid progeny of human CD34+ bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha
24. Interleukin-3 cooperates with tumor necrosis factor alpha for the development of human dendritic/Langerhans cells from cord blood CD34+ hematopoietic progenitor cells
25. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha
26. Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood
27. CD34+ peripheral blood progenitor cell and monocyte derived dendritic cells: A comparative analysis
28. IL-13 induces CD34+ cells isolated from G-CSF mobilized blood to differentiate in vitro into potent antigen presenting cells
29. Delineation of the dendritic cell lineage by generating large numbers of Birbeck granule-positive Langerhans cells from human peripheral blood progenitor cells in vitro
30. Generation of human dendritic cells/Langerhans cells from circulating CD34+ hematopoietic progenitor cells
31. Isolation of human blood dendritic cells using the CMRF-44 monoclonal antibody: Implications for studies on antigen-presenting cell function and immunotherapy
32. Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro
33. Ex vivo generation and function of dendritic cells in multiple myeloma
34. Differentiation of human dendritic cells from monocytes in vitro
35. Proliferating dendritic cell progenitors in human blood
36. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells
37. Mechanisms of tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-induced dendritic cell development
38. The role of tumor necrosis factor alpha in modulating the quantity of peripheral blood-derived, cytokine-driven human dendritic cells and its role in enhancing the quality of dendritic cell function in presenting soluble antigens to CD4+ T cells in vitro
39. Generation of human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factor
40. Identification of dendritic cell colony-forming units among normal human CD34+ bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha
41. TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors
42. The effect of Flt3 ligand and/or c-kit ligand on the generation of dendritic cells from human CD34+ bone marrow
43. Expansion of dendritic cells derived from human CD34+ cells in static and continuos perfusion cultures
44. Induction of tolerance by IL-10-treated dendritic cells
45. In vitro expansion and characterization of dendritic cells derived from human bone marrow CD34+ cells
46. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells
47. Dendritic cells require maturation via CD40 to generate protective antitumor immunity
48. A cryopreservation method of human peripheral blood mononuclear cells for efficient production of dendritic cells
49. Immunotherapeutic potential of tumor antigen-pulsed and unpulsed dendritic cells generated from murine bone marrow
50. Eradication of established murine tumors using a novel cell-free vaccine: Dendritic cell-derived exosomes
51. Dendritic cell based idiotype vaccination in multiple myeloma
52. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells
53. Butch: Dendritic Cell Biology and the Application of Dendritic Cells to Immunotherapy of Multiple Myeloma
54. Dendritic-cell-based cancer vaccines
55. Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy